CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (310) 358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 97 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-12 | Litvack Frank Director | Grant or award · Stock Option (Right to Buy) | +14,027 | 14,027 | ||
| 2020-02-12 | Litvack Frank Director | Grant or award · Stock Option (Right to Buy) | +154,543 | 154,543 | ||
| 2020-02-12 | Litvack Frank Director | Returned to the company · Stock Option (Right to Buy) | −23,750 | 0 | ||
| 2020-02-12 | Litvack Frank Director | Returned to the company · Stock Option (Right to Buy) | −6,000 | 0 | ||
| 2020-02-12 | Litvack Frank Director | Returned to the company · Stock Option (Right to Buy) | −2,500 | 0 | ||
| 2020-02-12 | Litvack Frank Director | Returned to the company · Stock Option (Right to Buy) | −3,937 | 0 | ||
| 2020-02-12 | Litvack Frank Director | Returned to the company · Stock Option (Right to Buy) | −25,000 | 0 | ||
| 2020-02-12 | Litvack Frank Director | Returned to the company · Stock Option (Right to Buy) | −20,748 | 0 | ||
| 2020-02-12 | Litvack Frank Director | Returned to the company · Stock Option (Right to Buy) | −14,027 | 0 | ||
| 2020-02-12 | Litvack Frank Director | Returned to the company · Stock Option (Right to Buy) | −154,543 | 0 | ||
| 2020-02-12 | COLLIER EARL M JR Director | Grant or award · Stock Option (Right to Buy) | +4,750 | 4,750 | ||
| 2020-02-12 | COLLIER EARL M JR Director | Grant or award · Stock Option (Right to Buy) | +3,050 | 3,050 | ||
| 2020-02-12 | COLLIER EARL M JR Director | Grant or award · Stock Option (Right to Buy) | +2,856 | 2,856 | ||
| 2020-02-12 | COLLIER EARL M JR Director | Grant or award · Stock Option (Right to Buy) | +2,437 | 2,437 | ||
| 2020-02-12 | COLLIER EARL M JR Director | Grant or award · Stock Option (Right to Buy) | +750 | 750 | ||
| 2020-02-12 | COLLIER EARL M JR Director | Grant or award · Stock Option (Right to Buy) | +1,401 | 1,401 | ||
| 2020-02-12 | COLLIER EARL M JR Director | Grant or award · Stock Option (Right to Buy) | +15,455 | 15,455 | ||
| 2020-02-12 | COLLIER EARL M JR Director | Returned to the company · Stock Option (Right to Buy) | −4,750 | 0 | ||
| 2020-02-12 | COLLIER EARL M JR Director | Returned to the company · Stock Option (Right to Buy) | −3,050 | 0 | ||
| 2020-02-12 | COLLIER EARL M JR Director | Returned to the company · Stock Option (Right to Buy) | −2,856 | 0 |
Page 17 of 24 · 468 trades